| CEO: | Stephen O'Hara |
| Finance Director: | David Blain |
| Non-Executive Chairman: | Neil Davidson |
| Research and Development Director: | Sofia Kolyda |
| Non-Executive Dir: | Sean Christie |
| Address: | Innovation Centre, Innovation Way, York, United Kingdom, YO10 5DG |
| Phone: | + 44 (0) 203 178 5618 |
| Website: | http://www.optibiotix.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BP0RTP38 |
| Currency | UK Pounds |
| Share Price | 8.25p |
| Change Today | -0.35p |
| % Change | -4.07 % |
| 52 Week High | 22.60p |
| 52 Week Low | 8.00p |
| Volume | 623,364 |
| Shares Issued | 103.30m |
| Market Cap | £8.52m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:16 | 15,427 @ 8.39p |
| 15:42 | 25,000 @ 8.06p |
| 15:41 | 10,000 @ 8.07p |
| 15:29 | 2,000 @ 8.40p |
| 15:06 | 3,000 @ 8.00p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research